These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 28904811)

  • 1. Which symptoms contribute the most to patients' perception of health in multiple sclerosis?
    Green R; Cutter G; Friendly M; Kister I
    Mult Scler J Exp Transl Clin; 2017; 3(3):2055217317728301. PubMed ID: 28904811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SymptoMScreen: A Tool for Rapid Assessment of Symptom Severity in MS Across Multiple Domains.
    Green R; Kalina J; Ford R; Pandey K; Kister I
    Appl Neuropsychol Adult; 2017; 24(2):183-189. PubMed ID: 27077687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the SymptoMScreen with performance-based or clinician-assessed outcomes.
    Fitzgerald KC; Salter A; Tyry T; Fox RJ; Cutter G; Mowry EM; Marrie RA
    Mult Scler Relat Disord; 2019 Apr; 29():86-93. PubMed ID: 30690340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How Multiple Sclerosis Symptoms Vary by Age, Sex, and Race/Ethnicity.
    Kister I; Bacon T; Cutter GR
    Neurol Clin Pract; 2021 Aug; 11(4):335-341. PubMed ID: 34476125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychometric Properties of the SymptoMScreen Questionnaire in a Mild Disability Population of Patients with Relapsing-Remitting Multiple Sclerosis: Quantifying the Patient's Perspective.
    Meca-Lallana J; Maurino J; Hernández-Pérez MÁ; Sempere ÁP; Brieva L; García-Arcelay E; Terzaghi M; Saposnik G; Ballesteros J
    Neurol Ther; 2020 Jun; 9(1):173-179. PubMed ID: 31955391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A longitudinal study of symptom botheration in Multiple Sclerosis.
    Kister I; Bacon T; Cutter GR
    Mult Scler Relat Disord; 2020 Nov; 46():102585. PubMed ID: 33296981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health perceptions and clinical characteristics of relapsing-remitting multiple sclerosis patients: baseline data from an international clinical trial.
    Robinson D; Zhao N; Gathany T; Kim LL; Cella D; Revicki D
    Curr Med Res Opin; 2009 May; 25(5):1121-30. PubMed ID: 19317608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autonomic symptom burden is associated with MS-related fatigue and quality of life.
    Cortez MM; Nagi Reddy SK; Goodman B; Carter JL; Wingerchuk DM
    Mult Scler Relat Disord; 2015 May; 4(3):258-63. PubMed ID: 26008943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of visible and invisible symptoms on employment status, work and social functioning in Multiple Sclerosis.
    Lorefice L; Fenu G; Frau J; Coghe G; Marrosu MG; Cocco E
    Work; 2018; 60(2):263-270. PubMed ID: 29400690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatigue during multiple sclerosis relapse and its relationship to depression and neurological disability.
    Šabanagić-Hajrić S; Suljić E; Kučukalić A
    Psychiatr Danub; 2015 Dec; 27(4):406-12. PubMed ID: 26609654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of fatigue, depression and the level of disability on the health-related quality of life of glatiramer acetate-treated relapsing-remitting patients with multiple sclerosis in Hungary.
    Fricska-Nagy Z; Füvesi J; Rózsa C; Komoly S; Jakab G; Csépány T; Jobbágy Z; Lencsés G; Vécsei L; Bencsik K
    Mult Scler Relat Disord; 2016 May; 7():26-32. PubMed ID: 27237753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-rated physical health predicts change in disability in multiple sclerosis.
    Drulovic J; Riise T; Nortvedt M; Pekmezovic T; Manigoda M
    Mult Scler; 2008 Aug; 14(7):999-1002. PubMed ID: 18505776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of quality of life in relapsing-remitting and progressive multiple sclerosis.
    Yalachkov Y; Soydaş D; Bergmann J; Frisch S; Behrens M; Foerch C; Gehrig J
    Mult Scler Relat Disord; 2019 May; 30():33-37. PubMed ID: 30735970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatigue in multiple sclerosis: relationship to depression, disability, and disease pattern.
    Kroencke DC; Lynch SG; Denney DR
    Mult Scler; 2000 Apr; 6(2):131-6. PubMed ID: 10773860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive reserve and symptom experience in multiple sclerosis: a buffer to disability progression over time?
    Schwartz CE; Quaranto BR; Healy BC; Benedict RH; Vollmer TL
    Arch Phys Med Rehabil; 2013 Oct; 94(10):1971-81. PubMed ID: 23727344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Quality of life assessment in patients with multiple sclerosis].
    Tepavcević DK; Pekmezović T; Drulović J
    Vojnosanit Pregl; 2009 Aug; 66(8):645-50. PubMed ID: 19780420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of psychological well‑being in multiple sclerosis rehabilitation.
    Fanciullacci C; Straudi S; Basaglia N; Chisari C
    Eur J Phys Rehabil Med; 2017 Feb; 53(1):105-113. PubMed ID: 27406880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal change in physical activity and its correlates in relapsing-remitting multiple sclerosis.
    Motl RW; McAuley E; Sandroff BM
    Phys Ther; 2013 Aug; 93(8):1037-48. PubMed ID: 23599354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No Increase in Symptoms Toward the End of the Ocrelizumab Infusion Cycle in Patients With Multiple Sclerosis: Symptom Burden on Ocrelizumab: A Longitudinal Study (SymBOLS).
    Kister I; Oh C; Douglas EA; Bacon TE; O'Shea IL; Parrotta EH; Bouley A; Lathi E; Katz J
    Neurol Clin Pract; 2023 Oct; 13(5):e200185. PubMed ID: 37674871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive symptoms and correlates of physical disability in individuals with multiple sclerosis.
    Fraser C; Stark S
    J Neurosci Nurs; 2003 Dec; 35(6):314-20. PubMed ID: 14713097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.